FI113543B - Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi - Google Patents

Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi

Info

Publication number
FI113543B
FI113543B FI954579A FI954579A FI113543B FI 113543 B FI113543 B FI 113543B FI 954579 A FI954579 A FI 954579A FI 954579 A FI954579 A FI 954579A FI 113543 B FI113543 B FI 113543B
Authority
FI
Finland
Prior art keywords
cyclohexylmethylenedioxy
dihydroxypregna
16alpha
11beta
epimers
Prior art date
Application number
FI954579A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954579A (fi
FI954579A0 (fi
Inventor
Beate Gutterer
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Rolf Beume
Karl Zech
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of FI954579A publication Critical patent/FI954579A/fi
Publication of FI954579A0 publication Critical patent/FI954579A0/fi
Application granted granted Critical
Publication of FI113543B publication Critical patent/FI113543B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI954579A 1993-04-02 1995-09-27 Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi FI113543B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02
PCT/EP1994/001015 WO1994022899A1 (de) 1993-04-02 1994-03-31 Neue prednisolonderivate

Publications (3)

Publication Number Publication Date
FI954579A FI954579A (fi) 1995-09-27
FI954579A0 FI954579A0 (fi) 1995-09-27
FI113543B true FI113543B (fi) 2004-05-14

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954579A FI113543B (fi) 1993-04-02 1995-09-27 Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi

Country Status (21)

Country Link
US (1) US5733901A (sk)
EP (1) EP0701565B1 (sk)
JP (1) JP3333210B2 (sk)
KR (1) KR100330941B1 (sk)
CN (1) CN1062869C (sk)
AT (1) ATE172739T1 (sk)
AU (1) AU683463B2 (sk)
BG (1) BG62491B1 (sk)
CZ (1) CZ287877B6 (sk)
DE (1) DE59407183D1 (sk)
DK (1) DK0701565T3 (sk)
ES (1) ES2124884T3 (sk)
FI (1) FI113543B (sk)
HU (1) HU220868B1 (sk)
NO (1) NO305990B1 (sk)
NZ (1) NZ265054A (sk)
PL (1) PL179489B1 (sk)
RU (1) RU2132854C1 (sk)
SK (1) SK281226B6 (sk)
UA (1) UA45311C2 (sk)
WO (1) WO1994022899A1 (sk)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
US7468433B2 (en) * 2000-11-10 2008-12-23 Nycomed Gmbh Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
ATE405275T1 (de) * 2002-12-12 2008-09-15 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
CA2528479A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
ATE476185T1 (de) * 2003-09-15 2010-08-15 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
AU2006259604A1 (en) * 2005-06-14 2006-12-28 Gilead Sciences, Inc. Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
AU2007298770B2 (en) * 2006-09-19 2013-01-31 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
CA2714653A1 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
ES2471145T3 (es) 2009-03-09 2014-06-25 Mikasa Seiyaku Co,. Ltd. Compuesto esteroide
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
PL3464318T3 (pl) 2016-06-02 2021-11-08 Abbvie Inc. Agonista receptora glukokortykoidowego i jego immunokoniugaty
US10772970B2 (en) 2017-12-01 2020-09-15 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
ATE172739T1 (de) 1998-11-15
CN1062869C (zh) 2001-03-07
AU683463B2 (en) 1997-11-13
PL179489B1 (pl) 2000-09-29
DE59407183D1 (de) 1998-12-03
KR100330941B1 (ko) 2002-10-12
BG100032A (bg) 1996-05-31
SK281226B6 (sk) 2001-01-18
JPH08508278A (ja) 1996-09-03
DK0701565T3 (da) 1999-07-12
ES2124884T3 (es) 1999-02-16
CZ287877B6 (cs) 2001-03-14
US5733901A (en) 1998-03-31
EP0701565B1 (de) 1998-10-28
WO1994022899A1 (de) 1994-10-13
NO953861D0 (no) 1995-09-29
JP3333210B2 (ja) 2002-10-15
SK122395A3 (en) 1996-01-10
NO305990B1 (no) 1999-08-30
CN1120339A (zh) 1996-04-10
PL311474A1 (en) 1996-02-19
EP0701565A1 (de) 1996-03-20
NZ265054A (en) 1997-08-22
HU9502819D0 (en) 1995-11-28
FI954579A (fi) 1995-09-27
RU2132854C1 (ru) 1999-07-10
BG62491B1 (bg) 1999-12-30
HU220868B1 (en) 2002-06-29
AU6538194A (en) 1994-10-24
NO953861L (no) 1995-09-29
CZ252995A3 (en) 1996-01-17
HUT72594A (en) 1996-05-28
UA45311C2 (uk) 2002-04-15
FI954579A0 (fi) 1995-09-27

Similar Documents

Publication Publication Date Title
FI113543B (fi) Menetelmä uuden terapeuttisesti käyttökelpoisen 16alfa,17-(22R,S)-sykloheksyylimetyleenidioksi-11beta,21-dihydroksipregna-1,4-dieeni-3,20-dionin ja sen epimeerien valmistamiseksi
RU95119827A (ru) Новые производные преднизолона
EE03927B1 (et) Meetod R-epimeeri suhtelise sisalduse suurendamiseks [11B,16a(R/S)]-16,17-[(tsükloheksüülmetüleen)bis(oksü)]-11-hüdroksü-21-(2-metüül-1-oksopropoksü)pregna-1,4-dieen-3,20-diooni R/S-epimeerses segus ja selle segu valmistamismeetod
NZ312303A (en) Novel nor-pregnanes for inducing hypothalamic effects
IE44473L (en) 6,9,21-trihalo pregnanes
HU9503578D0 (en) Androstane steroids as neurochemical initilators of change in human hypothalamic function and related pharmaceutical compositions and methods
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
BR0115220A (pt) Processo para a produção de 16,17-(ciclohexilmetilen)bis(óxi) -11,21-diidróxi-pregna-1,4-dien-3,20-diona ou seu 21-isobutirato por transcetalização
KR970706297A (ko) 시상하부의 효능을 유도하기 위한 신규 에스트렌류(novel estrenes for inducing hypothalamic effects)
GB1508745A (en) Steroidal(16alpha,17-d)cyclohexenes
AU1847892A (en) New substituted 16-methyl steroid derivatives of pregna-1,4-diene-3,20-dione, their preparation, their use in the preparation of 16-methylene steroids and new intermediates
YU22903A (sh) 17alfa-fluoroalkil steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
GB1527061A (en) Anti-inflammatory compositions containing steroids
AU1200097A (en) 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
CA2159627A1 (en) Novel prednisolone derivatives
FI946082A0 (fi) Menetelmä steroidisten perasyyliglykosidien valmistamiseksi

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NYCOMED GMBH

Free format text: NYCOMED GMBH

PC Transfer of assignment of patent

Owner name: TAKEDA GMBH

MA Patent expired